Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Eosinophil count

GLB1 · rs7646283

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−36, with 7 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 474,237 European ancestry individuals.

The effect Each copy of the T allele shifted the measure 0.026 SD unit higher (95% confidence interval 0.022-0.03); p = 2 × 10−36.

How common The T allele had a frequency of about 37% in the people studied.

Where it sits Chromosome 3, band 3p22.3 — in an intron of GLB1.

How common each version is

CT
Korean KRGDB
C 98.7% · T 1.3%
Korean Korea4K
C 98.6% · T 1.4%
Korean Korea1K
C 98.6% · T 1.4%
Japanese ToMMo
C 96.2% · T 3.8%
Vietnamese
C 99.1% · T 0.9%
World gnomAD
C 72.3% · T 27.7%
World 1000 Genomes
C 81.4% · T 18.6%
World TOPMed
C 73.0% · T 27.0%

By ancestry gnomAD

East Asian
C 98.0% · T 2.0%
European (non-Finnish)
C 62.0% · T 38.0%
African / African American
C 89.5% · T 10.5%
South Asian
C 71.5% · T 28.5%
Admixed American (Latino)
C 68.7% · T 31.3%
Middle Eastern
C 56.5% · T 43.5%
Finnish
C 69.4% · T 30.6%
Ashkenazi Jewish
C 55.7% · T 44.3%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Eosinophil count. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Eosinophil count. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Eosinophil count. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Eosinophil count (rs7646283). MyGeneLog™. https://www.mygenelog.com/variants/rs7646283

← See all variants